Johnson & Johnson's medical device segment saw 4.9 percent sales growth in the second quarter of 2017 and the segment is predicted to report expanded sales growth in the third quarter, according to Market Realist.
Here are four things to know:
1. The company expects to generate 5.5 percent to 6 percent of sales on operation basis in the third quarter of 2017.
2. Johnson & Johnson's recent expandable cage launch is expected to add the company's sales in the third quarter.
3. During the second quarter of 2017, Johnson & Johnson acquired Abbott Medical Optics for $4.3 billion, helping to drive sales growth. The company reported around $25 million in sales through acquired business lines for the second quarter.
4. Johnson & Johnson registered $18.8 billion in revenues in the second quarter of 2017, up around 1.6 percent year-over-year.